PWRM, MDU, ORFG, IND, BR - Your Weekend Stock Reports From Stock-PR.com!!

________________________________________

Power3 Medical Products, Inc. (PWRM.OB)

PWRM delivered four poster presentations at the 2010 ICAD. These presentations discussed PWRM’s diagnostic test, NuroPro, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

“In preparation for commercialization, our objective at this meeting was to show how Power3’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief Scientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”

“We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” commented Helen R. Park, MS, CEO of PWRM, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

PWRM has filed several patent applications that are currently pending for its NuroPro technology. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China. PWRM has also published 6 articles on NuroPro in peer-reviewed scientific journals. PWRM intends to publish these latest findings as well.

Power3 Medical Products, Inc., a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM’s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease. PWRM’s products analyze proteins and their mutations to assess an individual’s risk for developing disease later in life or a patient’s likelihood of responding to a particular drug; assess a patient’s risk of disease progression and disease recurrence; and measure a patient’s exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRM was founded in 1992 and is based in The Woodlands, Texas.

To learn more about PWRM visit: http://www.Power3Medical.com

____________________

MDU Resources Group Inc. (NYSE:MDU) announced that industry veteran J. Kent Wells will become president and chief executive officer of the corporation’s natural gas and oil production business, Fidelity Exploration & Production Company. Wells’ extensive experience spans more than 30 years with BP and Amoco, including responsibility for BP’s U.S. onshore natural gas business. He will report directly to MDU Resources president and chief executive officer Terry D. Hildestad beginning May 2, 2011 and will be based in Fidelity’s Denver headquarters.

MDU Resources Group Inc. operates as a natural resource company in the United States. The company provides electric retail, natural gas distribution, and natural gas transportation services.

____________________

Orofino Gold Corp. (ORFG.OB)

Orofino Gold Corp. (ORFG.PK) is pleased to announce the appointment of Mr. Salvador Rivero to the company’s Board of Directors.

Mr. Rivero brings to Orofino a wealth of knowledge in the areas of business, corporate finance, and mining operations. After graduating from law school in Mexico, Mr. Rivero spent the next 25 years developing a thorough understanding of the processes necessary to successfully discover, acquire, and develop, mineral concessions with the potential of containing valuable mineral deposits. Considered by Orofino as an acquisitions specialist, Mr. Rivero has been involved in the development of various turn-key projects in mining, energy, fertilizer, oil and gas, and shipping sectors.

At Orofino, Mr. Rivero, a Spanish-speaking executive, will assist in overseeing the acquisition of new properties. In addition, Mr. Rivero will utilize his extensive international experience in development and selection of partners for the progression toward large-scale production. Mr. Rivero will play a key role in the development of the properties in Orofino’s current Senderos de Oro gold camp in the mining area of central Sur de Bolivar, a project area comprised of more than 3000 hectares of mineral concessions in Colombia’s highest producing artisanal mining region.

Gold has been widely used throughout the world as a vehicle for monetary exchange, either by issuance and recognition of gold coins or other bare metal quantities, or through gold-convertible paper instruments by establishing gold standards in which the total value of issued money is represented in a store of gold reserves.

Because of the softness of pure (24k) gold, it is usually alloyed with base metals for use in jewelry, altering its hardness and ductility, melting point, color and other properties. Alloys with lower caratage, typically 22k, 18k, 14k or 10k, contain higher percentages of copper, or other base metals or silver or palladium in the alloy.

For centuries, buying gold has been recognized as one of the best ways to preserve one’s wealth and purchasing power. Gold is a unique investment, one that has served mankind well for thousands of years. From the times of ancient Egyptians, Greeks and Romans to more modern times, man has been fascinated with the beauty and magic of gold, and with its power to change men’s lives.

Orofino Gold Corp. engages in acquisition, exploration, and development of gold properties in Mexico and Colombia. ORFG has an option to acquire properties in the Sur de Bolivar Department of Colombia South America. ORFG was founded in 2005 and is based in Colombia.

To learn about ORFG visit: http://www.orofinogold.com

____________________

ING Groep NV (NYSE:IND) announced it will propose to the 2011 annual General Meeting (AGM) the appointment of three new members to the Supervisory Board; Sjoerd van Keulen, Joost Kuiper and Luc Vandewalle. Upon decision by the AGM, which will be held on 9 May, the appointment of the new members will be effective as of that date.

ING Groep N.V., a financial services company, provides banking, investment, life insurance, and retirement services worldwide. The company was founded in 1991 and is based in Amsterdam, the Netherlands.

____________________

Broadridge Financial Solutions Inc. (NYSE:BR) announced it has substantially enhanced the fixed income and financing functionality of its leading multi-asset trade processing and settlement solution, Gloss. The platform offers users additional processing support for tri-party repurchase agreements, auto-borrows and mortgage-backed securities as well as new P&L methodology and a Bloomberg interface. In parallel, Broadridge has extended its global fixed income client base for Gloss with three new implementations.

Broadridge Financial Solutions, Inc. provides technology-based solutions to the financial services industry in the United States, Canada, and the United Kingdom.

___

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer). Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.

Keywords: , ALS, alzheimers, amyotrophic, Ary Fernando Pernett Marque, BC-SeraPro, biotechnology, BR, Broadridge Financial, cancer, gold, gold mining, Helen Park, IND, ING, Ira Goldknopf, La Azul Mine, MDU, MDU Resources, mineral exploration, Ning Shi Long, Novartis, NuroPro, NYSE:BR, NYSE:IND, NYSE:MDU, ORFG, ORFG.PK, Orofino Gold, OTCBB:PWRM, Parkinsons, PINK:ORFG, power3 medical, proteomics, pwrm, PWRM.OB, Rozetta-Cell, Senderos de Oro, stem cells, Sur de Bolivar